BRCA2 Variants and cardiovascular disease in a multi-ethnic study

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Zbuk, Kevin ^a,f   Xie, Changchun ^a,f   Young, Robin ^b   Heydarpour, Mahyar ^a   Pare, Guillaume ^a,f   Davis, A D ^c   Miller, Ruby ^c   Lanktree, Matthew B ^d   Saleheen, Danish ^b,h,i   Danesh, John ^b   Yusuf, Salim ^a,f   Engert, James C ^e   Hegele, Robert A ^d   Anand, Sonia S ^a,f,g  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Six Nations Health Services   (Canada)

^d WESTERN UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h Center for Non Communicable Diseases   (Pakistan)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; CORONARY ARTERY BYPASS SURGERY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; EUROPE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH ASIA; STROKE; ALLELE; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; TUMOR SUPPRESSOR GENE;

ANGINA;

ALLELES; CARDIOVASCULAR DISEASES; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84864499487     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-56     Document Type: Article

References (31)

1. King MC, Marks JH, Mandell JB, . New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302(5645):643-646. 10.1126/science.1088759, 14576434, New York Breast Cancer Study Group.
2. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 2004, 22(4):735-742. 10.1200/JCO.2004.05.055, 14966099.
3. Mai PL, Chatterjee N, Hartge P, Tucker M, Brody L, Struewing JP, Wacholder S. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS One 2009, 4(3):e4812. 10.1371/journal.pone.0004812, 2652075, 19277124.
4. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007, 8(10):735-748.
5. Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B, Gupta A, Deng CX, Coles JG, Leong-Poi H, Stanford WL, Parker TG, Schneider MD, Finkel T, Verma S. BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2011, 2:593. 3247816, 22186889.
6. Singh KK, Shukla PC, Quan A, Desjardins JF, Lovren F, Pan Y, Garg V, Gosal S, Garg A, Szmitko PE, Schneider MD, Parker TG, Stanford WL, Leong-Poi H, Teoh H, Al-Omran M, Verma S. BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. J Biol Chem 2011,
7. Lynch HT, Silva E, Snyder C, Lynch JF. Hereditary breast cancer: part I, Diagnosing hereditary breast cancer syndromes. Breast J 2008, 14(1):3-13. 10.1111/j.1524-4741.2007.00515.x, 18086272.
8. Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 2004, 13(12):2078-2083.
9. Szabo C, Masiello A, Ryan JF, Brody LC. The breast cancer information core: database design, structure, and scope. Hum Mutat 2000, 16(2):123-131. 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y, 10923033.
10. Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001, 358(9288):1147-1153. 10.1016/S0140-6736(01)06255-9, 11597669.
11. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000, 356(9226):279-284. 10.1016/S0140-6736(00)02502-2, 11071182.
12. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, Chandrupatla HR, Hansen M, Ajmal S, Papanicolaou GJ, Guo Y, Li M, Derohannessian S, de Bakker PI, Bailey SD, Montpetit A, Edmondson AC, Taylor K, Gai X, Wang SS, Fornage M, Shaikh T, Groop L, Boehnke M, Hall AS, Hattersley AT, Frackelton E, Patterson N, Chiang CW, Kim CE, Fabsitz RR, Ouwehand W, Price AL, Munroe P, Caulfield M, Drake T, Boerwinkle E, Reich D, Whitehead AS, Cappola TP, Samani NJ, Lusis AJ, Schadt E, Wilson JG, Koenig W, McCarthy MI, Kathiresan S, Gabriel SB, Hakonarson H, Anand SS, Reilly M, Engert JC, Nickerson DA, Rader DJ, Hirschhorn JN, Fitzgerald GA. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008, 3(10):e3583. 10.1371/journal.pone.0003583, 2571995, 18974833.
13. Lanktree MB, Anand SS, Yusuf S, Hegele RA. SHARE Investigators: Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J Lipid Res 2009, 50(7):1487-1496. 10.1194/jlr.P900008-JLR200, 2694347, 19299407.
14. Lanktree MB, Johansen CT, Anand SS, Davis AD, Miller R, Yusuf S, Hegele RA. SHARE Investigators, SHARE-AP Investigators: Genetic variation in hyaluronan metabolism loci is associated with plasma plasminogen activator inhibitor-1 concentration. Blood 2010, 116(12):2160-2163. 10.1182/blood-2010-02-269902, 20558613.
15. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952. 10.1016/S0140-6736(04)17018-9, 15364185.
16. Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M, Kayani W, Faruqui A, Kundi A, Zaman KS, Yaqoob Z, Cheema LA, Samad A, Rasheed SZ, Mallick NH, Azhar M, Jooma R, Gardezi AR, Memon N, Ghaffar A, Fazal-ur-Rehman, Khan N, Shah N, Ali Shah A, Samuel M, Hanif F, Yameen M, Naz S, Sultana A, Nazir A, Raza S, Shazad M, Nasim S, Javed MA, Ali SS, Jafree M, Nisar MI, Daood MS, Hussain A, Sarwar N, Kamal A, Deloukas P, Ishaq M, Frossard P, Danesh J. The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol 2009, 24(6):329-338. 10.1007/s10654-009-9334-y, 2697028, 19404752.
17. Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, Bosch J, Sigouin C, Teo KK, Lonn E, Gerstein HC, Hegele RA, McQueen M. The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design, The SHARE Investigators. Can J Cardiol 1998, 14(11):1349-1357.
18. Serre D, Montpetit A, Pare G, Engert JC, Yusuf S, Keavney B, Hudson TJ, Anand S. Correction of population stratification in large multi-ethnic association studies. PLoS One 2008, 3(1):e1382. 10.1371/journal.pone.0001382, 2198793, 18196181.
19. Ehrich M, Bocker S, van den Boom D. Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res 2005, 33(4):e38. 10.1093/nar/gni038, 549577, 15731331.
20. http://www.illumina.com/pages.ilmn?ID=248.
21. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009, 5(6):e1000529. 10.1371/journal.pgen.1000529, 2689936, 19543373.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575. 10.1086/519795, 1950838, 17701901.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
24. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007, 39(7):906-913. 10.1038/ng2088, 17572673.
25. Weydert CJ, Esser AK, Mejia RA, Drake JM, Barnes JM, Henry MD. Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles. Cancer Biol Ther 2009, 8(8):720-729. 10.4161/cbt.8.8.7922, 19242129.
26. Yndestad A, Neurauter CG, Oie E, Forstrom RJ, Vinge LE, Eide L, Luna L, Aukrust P, Bjoras M. Up-regulation of myocardial DNA base excision repair activities in experimental heart failure. Mutat Res 2009, 666(1-2):32-38.
27. Slevin M, Elasbali AB, Miguel Turu M, Krupinski J, Badimon L, Gaffney J. Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol 2006, 168(3):1004-1021. 10.2353/ajpath.2006.050471, 1606543, 16507914.
28. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009, 10(4):241-251.
29. Rajasekaran R, Doss GP, Sudandiradoss C, Ramanathan K, Rituraj P, Sethumadhavan R. Computational and structural investigation of deleterious functional SNPs in breast cancer BRCA2 gene. Sheng Wu Gong Cheng Xue Bao 2008, 24(5):851-856.
30. Hao K, Chudin E, McElwee J, Schadt EE. Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies. BMC Genet 2009, 10:27. 2709633, 19531258.
31. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. 10.1038/nature05911, 2719288, 17554300, Wellcome Trust Case Control Consortium.